Abstract:Pyrazolone coumarin hybrids showed potential anticancer activity. MTT and Ethidium bromide/acridine orange staining, and DCFH‐DA assays have been carried out to assess cytotoxicity and reactive oxygen species which showed apoptosis pathway. For two active compounds, computational analyses using DFT for structural and electronic parameters is carried out followed by Molecular Docking to elucidate molecular interactions with p53 and caspase 3 proteins. Pursuing on our efforts towards searching for efficient anticancer agents herein we have designed and synthesized pyrazolone derivatives of 7‐amino 4‐methyl coumarin and 6‐amino coumarin. Anticancer activity of all the compounds were performed against lungs cancer cell line (A549) and breast cancer cell line (MCF‐7) using MTT assay. Out of all the compounds, compounds 17 c and 19 b exhibited remarkable activity with IC50 value of 1.22 μM and 1.66 μM against lungs cancer cell line (A549) breast cancer cell line (MCF‐7) respectively. Consequently, both compounds 17 c and compound 19 b were selected to study their cytotoxicity mechanism using different assays which includes EtBr/AO assay in respective cell, quantification of ROS using DCFH‐DA dye. To explore the behavioral and selective properties of the synthesized molecules, experimental analysis was complemented with computational methods. The electronic and structural parameters for both compound 17 c and 19 b were calculated using density functional theory (DFT) calculations and correlated with the observed biological activity. Molecular docking was conducted to explore the interaction of compounds 17 c and 19 b with pivotal apoptotic genes, namely p53 and caspase 3. Compound 17 c exhibited docking scores of −8.6 and −8.4 kcal/mol for p53 and caspase 3, while compound 19 b showed scores of −9.3 kcal/mol for both genes, significantly surpassing fluorouracil. Hence, compound 17 c and 19 b can be pursued for further studies, including molecular and In Vivo investigations.

Coumarin–furo[2,3- d ]pyrimidone hybrid molecules targeting human liver cancer cells: synthesis, anticancer effect, EGFR inhibition and molecular docking studies

Excellent antitumor and antimetastatic activities based on novel coumarin/pyrazole oxime hybrids

3,5-Dimethyl-h-7-furo[3,2-g]chromen-7-one As A Potential Anticancer Drug by Inducing P53-Dependent Apoptosis in Human Hepatoma Hepg2 Cells

Synthesis of pyrazolone derivatives of coumarin as anticancer agents

Coumarin-amino acid hybrids as promising anticancer agents: design, synthesis, docking studies and CK2 inhibition

Synthesis and Anticancer Evaluation of Novel Coumarin Derivatives

Novel Coumarin‐Pyrazole‐Thiazoles Hybrids: Synthesis, Anticancer Activity, Molecular Docking and In Silico ADMET prediction Studies

Synthesis and Biological Evaluation of a Novel Class of Coumarin Derivatives.

Synthesis and Molecular Docking Study of Novel Coumarin Derivatives Containing 4,5-Dihydropyrazole Moiety As Potential Antitumor Agents

Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis

Design, synthesis and biological evaluation of novel curcumin-fluorouracil hybrids as potential anti-cancer agents

Design, synthesis and anticancer activity studies of 3-(coumarin-3-yl)-acrolein derivatives: Evidenced by integrating network pharmacology and vitro assay

Novel Hybrids of 3-Substituted Coumarin and Phenylsulfonylfuroxan as Potent Antitumor Agents with Collateral Sensitivity against MCF-7/ADR.

Synthesis and anticancer activity of novel coumarin-stilbene hybrids with different hydrocarbon chains as linkers

Novel Coumarin-Dihydropyrazole Thio-Ethanone Derivatives: Design, Synthesis and Anticancer Activity.

Novel 8-Methoxycoumarin-3-Carboxamides with potent anticancer activity against liver cancer via targeting caspase-3/7 and β-tubulin polymerization

Coumarin hybrids: a sighting of their roles in drug targeting

Novel 3-(1-acetyl-5-(substituted-phenyl)-4,5-dihydro-1h-pyrazol-3-yl)-7-fluoro-2h-chromen-2-one Derivatives: Synthesis and Anticancer Activity

Synthesis and Biological Evaluation of Novel Furopyridone Derivatives as Potent Cytotoxic Agents against Esophageal Cancer

Novel Coumarin-Steroid/Terpenoid Hybrids: In Vitro and In Silico Anticancer Studies

Novel 1,2,3-Triazole-Coumarin Hybrid Glycosides and Their Tetrazolyl Analogues: Design, Anticancer Evaluation and Molecular Docking Targeting EGFR, VEGFR-2 and CDK-2